Myocardial protection during cardiac surgery can be accomplished by different cardioplegic solutions. The aim of this study was to assess myocardial damage after heart valve surgery performed with myocardial protection of a single dose of Celsior cardioplegia or with repeated cold blood cardioplegia. After the stratification of 139 valvular patients by means of matching according to cross-clamp and cardiopulmonary bypass time, 32 patients were retained for comparison (16 patients received Celsior and 16 patients received cold blood cardioplegia). Creatine kinase-MB (CK-MB) and cardiac troponin I (cTnI) release were evaluated until six days after the operation. Pre-operative characteristics were similar in both groups. In the Celsior group, CK-MB and cTnI values were significantly higher from the first up to the sixth post-operative day. Peak cTnI values were 19.4±13.4 and 9.7±7 ng/mL (p=0.01) in the Celsior and the Cold Blood group, respectively. Peak CK-MB values were 79.6±58.8 and 45.9±20.6 U/L (p=0.07) in the Celsior and the Cold Blood group, respectively. Cold blood cardioplegia reduces perioperative myocardial damage compared to the Celsior solution in elective cardiac valve operations.
MartinJBenkC. Blood cardioplegia. In: Multimedia Manual of Cardiothoracic Surgery MMCTS. doi:10.1510/mmcts.2004.000745.
2.
GuruVOmuraJAlghamdiAA. Is blood superior to crystalloid cardioplegia? A meta-analysis of randomized clinical trials. Circulation2006; 114 (1 Suppl): I331-I338.
3.
JacobSKallikourdisASellkeF. Is blood cardioplegia superior to crystalloid cardioplegia?Interact Cardiovasc Thorac Surg2008; 7: 491–498.
4.
BarnerHB. Blood cardioplegia: a review and comparison with crystalloid cardioplegia. Ann Thorac Surg1991; 52: 1354–1367.
5.
BjerrumJTPerkoMJBeckB. Myocardial oxygen tension during surgical revascularization. A clinical comparison between blood cardioplegia and crystalloid cardioplegia. Eur J Cardiothorac Surg2006; 29: 181–185.
6.
ØvrumETangenGTølløfsrudS. Cold blood versus cold crystalloid cardioplegia: a prospective randomised study of 345 aortic valve patients. Eur J Cardiothorac Surg2010; 38: 745–749.
7.
ØvrumETangenGTølløfsrudS. Cold blood cardioplegia versus cold crystalloid cardioplegia: a prospective randomized study of 1440 patients undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg2004; 128: 860–865.
8.
FanYZhangAMXiaoYB. Warm versus cold cardioplegia for heart surgery: a meta-analysis. Eur J Cardiothorac Surg2010; 37: 912–919.
9.
DurandyYHulinS. Intermittent warm blood cardioplegia in the surgical treatment of congenital heart disease: clinical experience with 1400 cases. J Thorac Cardiovasc Surg2007; 133: 241–246.
10.
FlamengWJHerijgersPDewildeS. Continuous retrograde blood cardioplegia is associated with lower hospital mortality after heart valve surgery. J Thorac Cardiovasc Surg2003; 125: 121–125.
SiegenthalerMP. Anterograde administration of cardioplegia. In: Multimedia Manual of Cardiothoracic Surgery MMCTS. doi:10.1510/mmcts.2004.000695.
13.
DoenstT. Direct cannulation of the coronary ostia. In: Multimedia Manual of Cardiothoracic Surgery MMCTS. doi:10.1510/mmcts.2004.000703.
14.
MaruyamaYChambersDJ. Myocardial protection: efficacy of a novel magnesium-based cardioplegia (RS-C) compared to St Thomas’ Hospital cardioplegic solution. Interact Cardiovasc Thorac Surg2008; 7: 745–749.
15.
KrononMTAllenBSHernanJ. Superiority of magnesium cardioplegia in neonatal myocardial protection. Ann Thorac Surg1999; 68: 2285–2291.
16.
YamaguchiSWatanabeGTomitaS. Lidocaine-magnesium blood cardioplegia was equivalent to potassium blood cardioplegia in left ventricular function of canine heart. Interact Cardiovasc Thorac Surg2007; 6: 172–176.
17.
BuckbergGD. Invited editorial on “Effects of glutamate and aspartate on myocardial substrate oxidation during potassium arrest”. J Thorac Cardiovasc Surg1996; 112: 1661–1663.
18.
NakamuraMThouraniVHRonsonRS. Glutathione reverses endothelial damage from peroxynitrite, the byproduct of nitric oxide degradation, in crystalloid cardioplegia. Circulation2000; 102(19Suppl. 3): III332–III338.
19.
BretschneiderHJHubnerGKnollD. Myocardial resistance and tolerance to ischemia: physiological and biochemical basis. J Cardiovasc Surg (Torino) 1975; 16: 241–260.
20.
AckemannJGrossWMoryM. Celsior versus Custodiol: early postischemic recovery after cardioplegia and ischemia at 5 degrees C. Ann Thorac Surg2002; 74: 522–529.
21.
LeeSHuangCSKawamuraT. Superior myocardial preservation with HTK solution over Celsior in rat hearts with prolonged cold ischemia. Surgery2010; 148: 463–473.
22.
PeredaDCastellaMPomarJL. Elective cardiac surgery using Celsior or St. Thomas No. 2 solution: a prospective, single-center, randomized pilot study. Eur J Cardiothorac Surg2007; 32: 501–506.
23.
HendrikxMJiangHGutermannH. Release of cardiac troponin I in antegrade crystalloid versus cold blood cardioplegia. J Thorac Cardiovasc Surg1999; 118: 452–459.
24.
PichonHChocronSAlwanK. Crystalloid versus cold blood cardioplegia and cardiac troponin I release. Circulation1997; 96: 316–320
25.
PaparellaDCappabiancaGVisicchioG. Cardiac troponin I release after coronary artery bypass grafting operation: effects on operative and midterm survival. Ann Thorac Surg2005; 80: 1758–1764.
26.
LasockiSProvenchèreSBénessianoJ. Cardiac troponin I is an independent predictor of in-hospital death after adult cardiac surgery. Anesthesiology2002; 97: 405–411.
27.
van GeeneYvan SwietenHANoyezL. Cardiac troponin I levels after cardiac surgery as predictor for in-hospital mortality. Interact Cardiovasc Thorac Surg2010; 10: 413–416.
28.
NesherNAlghamdiAASinghSK. Troponin after cardiac surgery: a predictor or a phenomenon?Ann Thorac Surg2008; 85: 1348–1354.
29.
CroalBLHillisGSGibsonPH. Relationship between postoperative cardiac troponin I levels and outcome of cardiac surgery. Circulation2006; 114: 1468–1475.
30.
Martínez-ComendadorJCastañoMMosqueraI. Cryoablation of atrial fibrillation in cardiac surgery: outcomes and myocardial injury biomarkers. J Cardiothorac Vasc Anesth2011; 25: 1030–1035.
